Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian Pharmaceutical Association (IPA) has urged small scale pharma manufacturing units in Madhya Pradesh, India, to seek government's urgent interference regarding the closure of the dying units.
Subscribe to our email newsletter
Addressing the problems faced by the small scale industry (SSI) sector, the MP Pharmaceutical Manufacturers Association, supported by IPA, is planning to submit a mass representation to the government demanding immediate measures to save the dying SSI units, reports pharmabiz.com.
IPA secretary S B Rijwani was quoted by Pharmabiz as saying that the defective pharma policy of the central government and the apathy of the state government towards the sector are the major reasons for the closure of many of them.
Because of the central government’s faulty policy, the units could not compete with those in the tax free zones, Rijwani said.
Another aspect for the closure of the industry is the stringent norms in the Drugs and Cosmetics Act, which instead of boosting, is suppressing the growth of the small scale sector.
The closure of the manufacturing units can be avoided by developing tax free zones in MP and introducing incentives and rescue measures to save the drug manufacturing companies from the present crisis, he added.